###begin article-title 0
###xml 73 78 <span type="species:ncbi:9606">human</span>
Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 436 441 <span type="species:ncbi:9606">human</span>
Potential therapeutic use of mesenchymal stem cells (MSCs) is likely to require large-scale in vitro expansion of the cells before transplantation. MSCs from adipose tissue can be cultured extensively until senescence. However, little is known on the differentiation potential of adipose stem cells (ASCs) upon extended culture and on associated epigenetic alterations. We examined the adipogenic differentiation potential of clones of human ASCs in early passage culture and upon senescence, and determined whether senescence was associated with changes in adipogenic promoter DNA methylation.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 176 182 176 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL</italic>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
###xml 227 234 227 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2 </italic>
###xml 305 312 305 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2 </italic>
###xml 316 320 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
###xml 361 367 361 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 509 512 509 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
###xml 514 520 514 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 522 528 522 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 532 536 532 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 845 849 845 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
ASC clones cultured to senescence display reduced adipogenic differentiation capacity in vitro, on the basis of limited lipogenesis and reduced transcriptional upregulation of FABP4 and LPL, two adipogenic genes, while LEP and PPARG2 transcription remains unaffected. In undifferentiated senescent cells, PPARG2 and LPL expression is unaltered, whereas LEP and FABP4 transcript levels are increased but not in all clones. Bisulfite sequencing analysis of DNA methylation reveals overall relative stability of LEP, PPARG2, FABP4 and LPL promoter CpG methylation during senescence and upon differentiation. Mosaicism in methylation profiles is maintained between and within ASC clones, and any CpG-specific methylation change detected does not necessarily relate to differentiation potential. One exception to this contention is CpG No. 21 in the LEP promoter, whose senescence-related methylation may impair upregulation of the gene upon adipogenic stimulation.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
Senescent ASCs display reduced in vitro differentiation ability and transcriptional activation of adipogenic genes upon differentiation induction. These restrictions, however, cannot in general be attributed to specific changes in DNA methylation at adipogenic promoters. There also seems to be a correlation between CpGs that are hypomethylated and important transcription factor binding sites.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 248 249 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 253 254 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 258 259 258 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 264 266 264 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 375 376 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 516 517 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 530 531 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 542 543 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 762 763 762 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 764 765 764 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 766 767 766 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 347 352 <span type="species:ncbi:9606">human</span>
###xml 379 384 <span type="species:ncbi:9606">Human</span>
Mesenchymal stem cells (MSCs) have been identified in many human tissues and are thought to be responsible for tissue homeostasis. Adipose tissue constitutes an abundant source of MSCs [1,2]. We have shown that adipose stem cells (ASCs) with a CD45-CD31-CD34+CD105+ phenotype can be isolated with ~99% purity from the stromal vascular fraction of human liposuction material [3]. Human ASCs exhibit primarily mesodermal differentiation capacity in vitro [1], and in vivo may contribute to improvements of osteogenic [4], neuronal [5], immune [6] and vascular functions [7]. ASCs display an immunophenotype similar to bone marrow MSCs and express genes extending across the three germ layers, supporting a differentiation potential toward non-mesodermal lineages [3,8,9].
###end p 9
###begin p 10
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 318 321 318 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
###xml 323 329 323 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 331 336 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4</italic>
###xml 338 341 338 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL</italic>
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYOG</italic>
###xml 390 394 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD31</italic>
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD144</italic>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1099 1101 1099 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1102 1104 1102 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1105 1107 1105 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 39 44 <span type="species:ncbi:9606">human</span>
Single cell-derived clonal cultures of human ASCs, however, show that differentiation capacity in vitro varies between cell clones [3]. Analysis of DNA methylation at promoters of lineage-specific genes showed that freshly isolated, undifferentiated ASCs display mosaically under-methylated adipogenic gene promoters (LEP, PPARG2, FABP4, LPL); in contrast, myogenic (MYOG) and endothelial (CD31, CD144) promoters are hypermethylated [10,11]. Methylation of a cytosine in a CpG dinucleotide is a heritable modification that favors genomic integrity, ensures proper regulation of gene expression and is essential for long-term gene silencing [12]. Methylation profiles are maintained in clonal ASC cultures up to 4 passages, or 20 population doublings from single cells, and do not correlate with gene expression level in undifferentiated or differentiated cells [10]. The unmethylated state of adipogenic promoters, together with the hypermethylation of endothelial and myogenic promoters and the maintenance of these methylation patterns after adipogenic, osteogenic or endothelial differentiation [10,11,13] suggest that ASCs are epigenetically committed to adipogenic differentiation preferentially over other lineages.
###end p 10
###begin p 11
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 16 <span type="species:ncbi:10090">murine</span>
Human and murine MSCs cultured in vitro undergo replicative senescence and exhibit reduced differentiation potential upon prolonged culture [14-19]. Loss of functionality of senescent MSCs is presumably due to accumulation of oxidative damage on DNA and proteins [20,21] and to telomerase dysfunction [22]. In vivo, reduced ability of MSCs to contribute to tissue repair in aged individuals has been attributed to a loss of MSC function rather than to diminished stem cell numbers [23].
###end p 11
###begin p 12
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 346 351 <span type="species:ncbi:9606">human</span>
Aging is accompanied by changes in DNA methylation in tumor suppressor genes [24] and by stochastic methylation events throughout the genome [25]. Culture may also induce random DNA methylation errors as a result of infidelity in maintenance DNA methylation [26,27]. In this study, we investigate the extent to which senescent clonal cultures of human ASCs exhibit reduced differentiation potential in vitro and whether this may be attributed to changes in promoter DNA methylation.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Senescent ASCs display reduced adipogenic differentiation potential
###end title 14
###begin p 15
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
To investigate the effect of senescence on differentiation ability of ASCs, we derived clonal cultures of ASCs from single freshly isolated cells [3]. The adipogenic differentiation capacity of these clones in early passage cultures (passage 4; P4) has been described previously [10]. Three clones, designated B1, B2 and B3, were cultured to senescence. Senescence was reached at passage P18 (i.e., after 48 population doublings) for clone B1, P16 (44 population doublings) for clone B2 and P17 (46 population doublings) for clone B3. Senescence was manifested by cell cycle arrest, as judged by the absence of cell division on the basis of cell counts upon at least two rounds of subculture after these passage numbers were reached (data not shown), and by typical enlarged cell morphology (Fig. 1A). Passage number achieved at senescence is referred to as Ps hereafter.
###end p 15
###begin p 16
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 273 278 <span type="species:ncbi:9606">human</span>
Adipogenic differentiation of human ASC clones in early and late passage. (A) Morphology of an ASC clone (B2) at P7 and at senescence (Ps). Arrow points to the nucleus of a large and flattened single cell at Ps. These phenotypes are typical for early passage and senescent human ASCs cultured clonally or as polyclones. (B) Three ASC clones (B1, B2, B3) were induced to differentiate toward the adipogenic pathway for three weeks, starting at P7 (B) or Ps (C). Ps corresponded to P18 (clone B1), P16 (clone B2) and P17 (clone B3). Cells were stained with Oil Red-O to visualize lipid droplets and with hematoxylin to visualize nuclei. Bars, 100 mum.
###end p 16
###begin p 17
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 434 436 434 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
To evaluate the differentiation capacity of early passage vs. senescent cells, all clones were induced to differentiate toward the adipogenic pathway for three weeks, starting either at P7 or at Ps. All P7 clones differentiated efficiently, on the basis of Oil Red-O staining (Fig. 1B). Differentiation, however, was impaired in senescent cells (Fig. 1C, Ps). Note that differentiation was elicited for each clone with 20,000 cells/cm2 both at P7 and at Ps, so we could not attribute differences in the extent of adipogenesis to differences in cell density.
###end p 17
###begin p 18
###xml 338 344 338 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 444 446 444 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 508 513 508 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4</italic>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 594 596 594 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 652 654 652 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 759 762 759 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL</italic>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 942 944 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 963 966 963 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
###xml 1068 1070 1068 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1118 1120 1118 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
Quantitative analysis of expression of adipogenic genes in undifferentiated P7 and Ps cells by real time reverse transcription (RT) polymerase chain reaction (PCR) corroborated the reduced ability of senescent ASCs to commit to adipogenesis. In undifferentiated P7 cells, expression of peroxisome proliferator-activated receptor gamma 2 (PPARG2) occurred at low levels and was not significantly altered in senescent cells in any of the clones (P > 0.05; Fig. 2A). Expression of fatty acid-binding protein 4 (FABP4) [28] mRNA, also detected at low levels at P7, was unaltered at Ps in clone B2 (P > 0.1), but was upregulated 3-fold in clones B1 and B3 (P < 0.01 for each clone, relative to undifferentiated cells; Fig. 2A). Transcripts for lipoprotein lipase (LPL) were undetectable at P7 or Ps in clones B2 and B3, consistent with previous observations [10], but were expressed at a low level in both P7 and senescent cells in clone B1 (Fig. 2A). Lastly, leptin (LEP) mRNA was undetected in clone B1 but was upregulated 5- to 6-fold at senescence in clones B2 and B3 (P < 0.01 relative to undifferentiated cells; Fig. 2A). It is noteworthy however, that all transcripts detected in undifferentiated P7 ASCs were expressed at very low levels, as illustrated by elevated Ct values (> 35) despite high real time PCR efficiency (data not shown).
###end p 18
###begin p 19
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
###xml 87 93 87 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
Expression of adipogenic genes upon differentiation of P7 and senescent ASCs. (A) LEP, PPARG2, FABP4 and LPL transcript levels were determined in undifferentiated Ps cells (clones B1, B2, B3) relative to undifferentiated P7 cells. For each clone, the mRNA level detected at P7 was attributed a value of 1 and the mRNA level in the same clone at Ps was expressed relative to that. A value of 0 (no bar) indicates that the gene is not expressed. (B) At senescence, each clone was induced to differentiate and mRNA levels compared to those of undifferentiated cells (level 1). 'ND' indicates that the gene was upregulated but relative levels could not be determined because transcripts were undetected in undifferentiated cells (jagged bars). (C) Transcript levels in cells differentiated at P7 were expressed relative to those in cells differentiated at Ps (level 1). Each panel shows the mean fold upregulation from triplicate RT-PCRs from at least two separate cDNA preparations.
###end p 19
###begin p 20
###xml 139 141 139 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
###xml 225 227 225 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 403 405 403 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 848 850 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 902 906 902 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 943 947 943 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
###xml 1064 1066 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1082 1088 1082 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 1092 1096 1092 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 1225 1227 1225 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1238 1244 1238 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 1248 1250 1248 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1262 1265 1262 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL</italic>
###xml 1278 1279 1278 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1302 1309 1302 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2 </italic>
###xml 1313 1317 1313 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
###xml 1337 1339 1337 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1358 1359 1358 1359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1371 1373 1371 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
Three weeks of adipogenic stimulation initiated at Ps promoted upregulation of all genes relative to undifferentiated cells in all clones (P < 0.01 for any gene examined), except for LEP which remained unchanged in clone B3 (P > 0.1; Fig. 2B). Extent of gene upregulation varied between clones, reflecting differences in the ability of each clone to commit to adipogenesis even in late passage culture (P < 0.01 between clones, for each gene). This is similar to what we previously observed with the same clones at passage 4 [10]. Note, however, that a significant part of this variation was due to the low levels of transcripts detected in undifferentiated cells, small variations in which can result in large differences in relative upregulation upon differentiation (small variations in PCR efficiency also affect quantification of mRNA levels [29]). Although transcriptional activation took place, LPL mRNA levels in clones B2 and B3, and LEP mRNA level in clone B3 could not be quantified as these genes were not expressed in undifferentiated cells (see Fig. 2A). Furthermore, FABP4 and LPL mRNA levels in ASCs after three weeks of adipogenic stimulation at P7 were higher than after induction of differentiation at Ps (P < 0.05 for FABP4 and P < 0.005 for LPL; one-sample t-test), while those of PPARG2 and LEP were not different (P > 0.05, one-sample t-test; Fig. 2C). Impaired lipid accumulation and transcriptional activation of adipogenic genes during culture of ASCs to senescence illustrate a reduced commitment to adipogenesis, despite stable or moderately upregulated transcript levels in undifferentiated cells.
###end p 20
###begin title 21
Adipogenic promoter DNA methylation profiles remain stable upon culture to senescence
###end title 21
###begin p 22
###xml 171 174 171 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
###xml 176 182 176 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 184 190 184 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 641 644 641 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
###xml 646 652 646 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 654 660 654 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 664 668 664 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 998 1000 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1002 1004 1002 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1008 1011 1008 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-4 </sup>
###xml 1030 1031 1030 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 898 903 <span type="species:ncbi:9606">human</span>
To determine whether reduced transcriptional level of adipogenic genes in senescent ASCs had an underlying epigenetic basis, we assessed the DNA methylation status in the LEP, PPARG2, FABP4 and LPL promoters by bisulfite sequencing. Bisulfite conversion of DNA relies on the deamination of unmethylated cytosines into uracils, while methylated cytosines are protected from deamination. PCR converts uracils to thymidines and sequencing of several PCR products cloned in bacteria enables a quantitative assessment of the position and number of methylated cytosines in the region examined [30]. Regions analyzed by bisulfite sequencing in the LEP, PPARG2, FABP4 and LPL promoters are shown in Fig. 3A. We first validated the significance of the regions examined by showing that the extent of methylation was consistently lower in all promoters in differentiated SGBS (Simpson-Golabi-Behmel Syndrome) human adipocytes (0-45% methylated CpGs) than in peripheral blood T cells (24-72% methylation; Fig. 3B; P < 10-4 for each promoter; t-test).
###end p 22
###begin p 23
###xml 140 143 140 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
###xml 145 151 145 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 153 159 153 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 163 167 163 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 321 324 321 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
###xml 326 332 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 334 340 334 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 344 348 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 376 381 <span type="species:ncbi:9606">human</span>
DNA methylation analysis of adipogenic promoters in human adipocytes and T cells. (A) Map of CpG dinucleotides (tick marks) examined in the LEP, PPARG2, FABP4 and LPL promoters. Regions examined are indicated by the continuous line. Numbers are relative to the transcription start site (TSS). (B) Bisulfite sequencing of LEP, PPARG2, FABP4 and LPL promoters in differentiated human SGBS adipocytes and in purified peripheral blood T cells. Ten bacterial clones of PCR products were sequenced. Each row represents one bacterial clone with one circle symbolizing one CpG. Top numbers indicate position of CpGs relative to the TSS. Bottom numbers are CpG numbers, with No. 1 being the 5'-most cytosine in the sequence examined.
###end p 23
###begin p 24
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 172 184 172 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP, PPARG2 </italic>
###xml 188 192 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 318 334 318 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Undifferentiated</italic>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 649 655 649 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 794 795 794 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 797 813 797 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Undifferentiated</italic>
###xml 831 832 831 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1023 1025 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
DNA methylation profiles of undifferentiated senescent cells are shown in Fig. 4A and illustrated for all individual clones in Additional file 1, Supplementary Fig. 1. The LEP, PPARG2 and LPL promoters were largely hypomethylated in all clones examined, with percentages of methylation ranging from 7 to 29% (Table 1, Undifferentiated). We found that the preferred areas of methylation in each locus we previously identified in early passage (P4) cells [10] were maintained in Ps cells (Fig. 4A). Furthermore, as in P4 cells, methylation profiles were mosaic in senescent cells, both between ASC clones and within a clonal population (Fig. 4A). The FABP4 promoter displayed greater variation in global methylation with clone B2 being 25% methylated, while B3 was 75% methylated (Fig. 4A; Table 1, Undifferentiated; Additional file 1, Supplementary Fig. 1C). Note that although adipogenic differentiation potential was evaluated in ASCs at P7 in this study, early passage methylation status was previously determined at P4 [10]; however no or minimal methylation differences were anticipated between P4 and P7, relative to senescence (P16-18).
###end p 24
###begin p 25
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
Percentage of CpG methylation in the LEP, PPARG2, FABP4 and LPL promoters in undifferentiated and differentiated ASC clones at passage 4 (P4) and at senescence (Ps)
###end p 25
###begin p 26
###xml 18 20 18 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 20 22 20 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 31 33 31 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 33 35 33 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 44 46 44 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
###xml 46 48 46 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ns </sup>
Chi-square tests: a P < 0.001; b P < 0.005; c P < 0.05; ns non-significant.
###end p 26
###begin p 27
###xml 160 163 160 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 173 179 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 738 739 738 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 767 769 767 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 780 782 780 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 791 792 791 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
DNA methylation analysis of adipogenic promoters in undifferentiated and differentiated ASCs at passage 4 (P4) and senescence (Ps). (A) Bisulfite sequencing of LEP, PPARG2, FABP4 and LPL in undifferentiated Ps cells. Numbers are as in Figure 3. (B) Percentage of individual methylated CpGs (● in A) in undifferentiated P4 (green) and Ps (red) cells (average of clones B1, B2, B3). Data for individual undifferentiated ASC clones are shown in Additional file 1, Supplementary Figure. (C) Bisulfite sequencing of Ps cells after adipogenic differentiation. Numbers are as in Figure 3. (D) Percentage of individual methylated CpGs (● in C) in differentiated cells at Ps. Data for individual differentiated clones are shown in Additional file 1, Supplementary Figure 2. **P < 0.01, ***P < 0.001 (t-tests).
###end p 27
###begin p 28
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 266 271 266 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A, B</xref>
###xml 328 334 328 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FAPB4 </italic>
###xml 349 351 349 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 362 364 362 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 538 542 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 550 552 550 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 561 562 561 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 810 813 810 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
###xml 815 822 815 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2 </italic>
###xml 826 832 826 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 929 933 929 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
###xml 937 943 937 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FAPB4 </italic>
###xml 981 982 981 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 984 1000 984 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Undifferentiated</italic>
###xml 1003 1007 1003 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 1117 1118 1117 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1120 1136 1120 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Undifferentiated</italic>
Methylation profiles of each promoter in senescent cells (Fig. 4B, red lines) were compared to those obtained earlier [10] in the same ASC clones cultured to P4 (Fig. 4B, green lines). Methylation profiles remained overall similar during culture to senescence (Fig. 4A, B). However, two CpGs were found to be hypermethylated in FAPB4 (CpGs 1 and 2; P < 0.01 and P < 0.001, respectively; t-tests), owing to hypermethylation in clones B1 and B3 (Additional file 1, Supplementary Fig. 1C). Moreover, we found one CpG to be hypomethylated in LPL (CpG 6; P < 0.001; t-test; Fig. 4B) also owing to demethylation of this cytosine in clones B1 and B3 (Additional file 1, Supplementary Fig. 1D). When global percentages of methylation were compared between undifferentiated individual ASC clones at P4 and Ps, however, LEP, PPARG2 and FABP4 were found to be hypermethylated upon senescence in clone B1, while clones B2 and B3 only showed LEP and FAPB4 hypermethylation, respectively (Table 1, Undifferentiated). LPL promoter methylation was reduced between P4 and Ps in clone B1 and remained stable in the other clones (Table 1, Undifferentiated).
###end p 28
###begin p 29
###xml 205 211 205 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
These results indicate that overall, adipogenic promoters retain the largely hypomethylated profile that characterizes ASCs. Nevertheless, a few CpGs become hyper- or hypomethylated upon senescence in the FABP4 and LPL promoters, respectively, albeit not in all clones.
###end p 29
###begin title 30
Adipogenic differentiation maintains methylation profiles at adipogenic promoters in senescent ASCs
###end title 30
###begin p 31
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
###xml 280 285 280 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C, D</xref>
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 296 310 296 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Differentiated</italic>
###xml 376 378 376 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 386 387 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 516 518 516 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 527 528 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 542 543 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 545 559 545 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Differentiated</italic>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 648 654 648 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 713 718 713 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C, D</xref>
###xml 726 727 726 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 729 743 729 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Differentiated</italic>
###xml 745 747 745 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 756 757 756 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 821 823 821 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 850 851 850 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 865 866 865 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 884 885 884 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 915 921 915 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 925 929 925 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 1029 1034 1029 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C, D</xref>
###xml 1064 1070 1064 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 1121 1122 1121 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1178 1179 1178 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1351 1352 1351 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1399 1401 1399 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1406 1408 1406 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 1467 1471 1467 1471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
###xml 1486 1487 1486 1487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1489 1491 1489 1491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1499 1500 1499 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
We next examined the methylation profile of adipogenic promoters after adipogenic stimulation in senescent cells and compared these profiles to those of cells differentiated at P4 [10]. Methylation patterns were similar in the LEP promoter in differentiated P4 and Ps cells (Fig. 4C, D; Table 1, Differentiated), with only two CpGs, No. 5 and 21, being hypermethylated at Ps (P < 0.01; t-tests; Fig. 4D). Upon examination of individual clones, however, clones B2 and B3 displayed enhanced methylation at senescence (P < 0.001; t-tests; Table 1, Differentiated) due to hypermethylation of several CpGs (Additional file 1, Supplementary Fig. 2A). In PPARG2, enhanced methylation was seen at Ps compared to P4 (Fig. 4C, D; Table 1, Differentiated; P = 0.011; t-test) due to hypermethylation of CpGs No. 4, 5 and 6 (Fig. 4D; P < 0.001 for each cytosine; t-tests; Table 1; Additional file 1, Supplementary Fig. 2B). The FABP4 and LPL promoters displayed remarkably similar methylation profiles in Ps and P4 differentiated cells (Fig. 4C, D), with only clone B3 showing FABP4 hypermethylation in differentiated Ps cells (Table 1) due to enhanced methylation of CpG 2 (Additional file 1, Supplementary Fig. 2C). Finally, we found that methylation profiles of all promoters were overall similar in undifferentiated and in adipogenic-stimulated Ps cells (Fig. 5, showing a direct comparison of data of Figs. 4B and 4D, red curves), except for hypermethylation of CpG 5 in the LEP promoter (Fig. 5; P < 0.01; t-test). We concluded that overall, methylation patterns in adipogenic promoters are similar between adipogenic-stimulated cells in early passage and at senescence. However, as with undifferentiated cells, specific CpGs appear to be hyper- or hypomethylated in a promoter-specific and cell clone-specific manner.
###end p 31
###begin p 32
###xml 257 259 257 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 267 268 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
DNA methylation profiles of adipogenic promoters in undifferentiated and in adipogenic stimulated senescent ASCs. Data were obtained by bisulfite sequencing as shown in Figure 4. Percentages of methylated CpGs are shown (average of clones B1, B2 and B3). **P < 0.01 (t-test).
###end p 32
###begin p 33
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
###xml 154 159 154 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A, C</xref>
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
We occasionally noted the substitution of a cytosine for a thymidine (C:T substitutions) in some LEP bisulfite sequences, consistently at CpG No. 4 (Fig. 4A, C, blue marks). Sequences were unambiguous and displayed either a methylated C or an unmethylated C (the latter read as A, as shown in Additional file 1, Supplementary Fig. 3A) or, unexpectedly a T (read as a T; Additional file 1, Supplementary Fig. 3B). To account for this substitution, it has been proposed that CpG methylation increases the mutation rate from CpG to TpG or CpA, as suggested by the lower number of CpGs observed over that expected in mammalian genomes [31,32].
###end p 33
###begin p 34
In summary, methylation profiles at adipogenic promoters are generally maintained upon clonal culture of ASCs to senescence. Nevertheless, at the level of individual clones, methylation may be differentially affected in a gene-independent manner, but this does not necessarily correlate with transcriptional changes. Adipogenic stimulation of early passage or senescent cells does not markedly affect adipogenic promoter DNA methylation.
###end p 34
###begin title 35
Discussion
###end title 35
###begin title 36
Reduced adipogenic differentiation potential of senescent ASCs is not related to changes in promoter DNA methylation
###end title 36
###begin p 37
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 518 524 518 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 528 532 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 660 666 660 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 668 671 668 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL</italic>
###xml 697 702 697 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4</italic>
###xml 704 707 704 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
Little is known on alterations in DNA methylation in MSCs during in vitro aging and how these may relate to changes in differentiation potential. We examined three clonal lines of ASCs with an ability to differentiate toward adipogenic [10], osteogenic and endothelial pathways [11,13]. Similarly to cultured bone marrow MSCs [20,33], all ASC clones cultured to senescence displayed reduced adipogenic differentiation potential in vitro, on the basis of lipid synthesis and transcriptional upregulation of, primarily, FABP4 and LPL relative to the same clones in early passage cultures. Interestingly however, basal transcription of these genes was unaltered (PPARG2, LPL) or moderately enhanced (FABP4, LEP) in undifferentiated cells at Ps. Thus, reduced transcription efficiency in differentiated senescent cells cannot be attributed to lower transcript levels in the undifferentiated state.
###end p 37
###begin p 38
###xml 81 87 81 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 336 340 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 619 620 615 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 728 730 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 739 741 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 760 762 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1010 1012 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1013 1015 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1190 1192 1178 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
What may be the basis for reduced adipogenic potential in senescent ASCs? First, PPARG2, a master regulator of adipogenesis [34], is upregulated to a level similar in early passage and senescent cells, thus we cannot explain reduced adipogenesis by PPARgamma insufficiency. Second, adipogenic stimulation of senescent cells upregulates LPL expression, albeit to a lower level than in early passage cells. A suboptimal transcription level is likely to affect translation, preventing further phenotypic changes. Of note, transcription without detectable protein expression seems to be a feature of undifferentiated ASCs [3]. Third, transcription or synthesis of transcriptional regulators of adipogenic genes, such as C/EBPalpha [34], BMP4 [35] or ADD1/SREBP1c [36] may be compromised in senescent cells and may account for adipogenesis deficiency despite the putative availability of binding sites (see below). Indeed, failure to express C/EPBalpha results in inability to develop white adipose tissue in vivo [37,38]. Fourth, adipogenic failure may also be due to impaired downregulation of GATA2/3, pre-adipocyte factor 1 or Wnt10b, whose expression blocks cells in a pre-adipocyte stage [39].
###end p 38
###begin p 39
###xml 157 160 157 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
###xml 162 168 162 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 170 176 170 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 260 263 260 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
###xml 265 272 265 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2 </italic>
###xml 276 280 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 318 324 318 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
To determine whether there was an epigenetic basis for reduced differentiation potential in senescent cells, we examined the DNA methylation profiles in the LEP, PPARG2, FABP4 and LPL promoters. Senescent cells maintained the overall mosaic hypomethylation of LEP, PPARG2 and LPL previously reported in P4 cells [10]. FABP4 exhibited hypermethylation in two undifferentiated ASC clones (B1, B3) at senescence. However, this did not correlate with reduced transcription potential upon adipogenic stimulation because clone B2, which is not hypermethylated at senescence, showed similar a reduction in transcription level to clones B1 and B3. Mosaic methylation has been reported in other primary cell cultures [26,27,40] and is likely the result of stochastic errors in maintenance methylation which occur over many rounds of replication. On the basis of our observations, therefore, it is difficult to attribute any change in promoter methylation to an effect of senescence per se.
###end p 39
###begin title 40
Relationship between CpG methylation and binding of transcriptional regulators
###end title 40
###begin p 41
###xml 221 225 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 745 749 741 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
###xml 761 763 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 764 766 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 988 992 984 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
###xml 1071 1075 1067 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
###xml 1287 1291 1283 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
Identification of relationships between the most hypomethylated areas in adipogenic promoters and binding sites for transcription factors argues that most, but not all, these sites remain available during culture. In the LEP promoter, methylation of CpGs No. 4-6 in clones B2 and B3 covers a recognition site for the methyl-CpG binding protein Kaiso [41,42]. Moreover, two Sp1binding sites span CpGs No. 15 and 16 while CpG No. 17 lies in a site occupied by an unidentified factor [43]. CpGs No. 15-17 are unmethylated at P4 and at senescence, presumably leaving these binding sites available. Additionally, CpG No. 21 lies within a C/EBPalpha recognition site flanked by E boxes for putative ADD1/SREBP1 binding, all of which are important for LEP expression [43,44]. In contrast to CpGs No.15-17, CpG No. 21 is hypermethylated in senescent ASCs, but only in the context of adipogenic stimulation, in clones B1 and B3. CpG No. 21 hypermethylation may account for limited or undetectable LEP upregulation in adipogenic stimulated senescent cells. Moreover, we found that LEP transcripts increased 5-6-fold in undifferentiated senescent clones B2 and B3, but not in clone B1, which displayed heaviest methylation on CpG No.21. Therefore, methylation of CpG No.21 correlates with impaired LEP transcriptional upregulation in senescent cells in the context of adipogenic stimulation.
###end p 41
###begin p 42
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 533 537 533 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 672 678 672 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 822 824 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 883 885 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
Methylation profiles of the LPL and FABP4 promoters further illustrates a functional relationship between DNA methylation and transcription factor binding. The LPL promoter contains a PPAR responsive element between CpGs No. 7 and 8 [45,46], a sterol-responsive element acting as binding site for SREBP1c [36], and between CpGs No. 9 and 10, a CAAT box and a binding sequence for Oct1 and TFIIB. Notably, CpGs No. 7-11 are consistently unmethylated in both early and late passage ASCs, thereby enabling transcriptional activation of LPL upon differentiation even in senescent cells. Availability of transcription factor binding sites in senescent ASCs also yields for the FABP4 promoter, which is strongly activated upon adipogenic stimulation. Notably, this promoter harbors a C/EBPalpha binding site close to CpG No. 4 [47], the only cytosine unmethylated regardless of ASC donor [10], cell clone and differentiation state in early passage and in senescent cells.
###end p 42
###begin title 43
Promoter DNA methylation during senescence and aging
###end title 43
###begin p 44
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 949 951 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 102 107 <span type="species:ncbi:9606">human</span>
Stochastic methylation in senescing ASCs is reminiscent of random methylation patterns established in human intestinal crypt stem cells in aging individuals [48,49]. Aging-related random methylation has been proposed to occur as a result of failure of maintenance methyltransferase activity, and/or exposure to environmental factors and health of the individual [24,50,51]. Our results provide evidence that methylation changes detected in senescent ASCs do not correlate with transcriptional defects and reduced differentiation potential. Likewise, there is to date little evidence linking DNA methylation of lineage-specific genes and aging-related impairment of stem cell function (tissue homeostasis) [20], stochastic changes in gene expression [52] and genome integrity [53]. Nevertheless, comparing aging to in vitro replicative senescence should be made with caution, as age of MSCs does not always affect differentiation potential in vitro [54].
###end p 44
###begin p 45
###xml 402 406 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
In summary, our results argue that reduction of adipogenic potential in senescent ASCs may relate to transcriptional defects upon adipogenic stimulation. However, it cannot in general be attributed to specific methylation changes in adipogenic promoters, and thereby to availability of transcription factor binding sites regulated by CpG methylation. One exception to this contention is one CpG in the LEP promoter (CpG No. 21 in the present study), whose senescence-related methylation may impair upregulation of the gene upon adipogenic stimulation. There also seems to be a correlation between regions of CpGs hypomethylation and important transcription factor binding sites.
###end p 45
###begin title 46
Conclusion
###end title 46
###begin p 47
ASCs cultured to senescence display reduced in vitro differentiation ability and transcriptional activation of adipogenic genes. These restrictions, however, cannot be attributed to specific changes in DNA methylation on adipogenic promoters. There also seems to be a correlation between CpGs that are hypomethylated and important transcription factor binding sites.
###end p 47
###begin title 48
Methods
###end title 48
###begin title 49
Adipose stem cell isolation and clonal culture
###end title 49
###begin p 50
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 417 419 417 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 467 469 467 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 605 606 605 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 611 612 611 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 670 671 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1137 1139 1137 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1140 1142 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1143 1145 1143 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 104 109 <span type="species:ncbi:9606">human</span>
###xml 535 540 <span type="species:ncbi:9606">human</span>
###xml 797 803 <span type="species:ncbi:9913">bovine</span>
###xml 872 878 <span type="species:ncbi:9913">bovine</span>
Cells with a CD45-CD31-CD34+CD105+ phenotype (ASCs) were isolated from the stromal vascular fraction of human adipose tissue as described [3]. In short, lipoaspirates obtained from the hip or thigh regions of female donors below 40 years of age were digested with collagenase and DNase I, and adipocytes were separated from stromal vascular cells by centrifugation. Stromal cells were strained through sieves and CD45- cells were retrieved by negative selection. CD31- cells were in turn negatively selected using FITC-conjugated anti-human CD31 antibodies and anti-FITC microbeads. Isolated ASCs are CD34+CD105+so no negative selection was performed for these markers [3]. For clonal expansion, single freshly isolated ASCs were cultured in 48-well plates in DMEM/F12 medium containing 50% fetal bovine serum. After ~16 h, the medium was replaced with DMEM/F12/10% fetal bovine serum and after 3 weeks, colonies were passaged by trypsinization. The three ASC clones used in this study (clones B1, B2, B3) have been previously characterized for their ability to differentiate toward adipogenic, osteogenic and endothelial cell lineages [10,11,13].
###end p 50
###begin title 51
Adipogenic differentiation
###end title 51
###begin p 52
###xml 311 312 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
Cells were cultured to confluency in DMEM/F12/10% serum and stimulated for 3 weeks with 0.5 mM 1-methyl-3 isobutylxanthine, 1 muM dexamethasone, 10 mug/ml insulin (Novo Nordisk) and 200 muM indomethacin (Dumex-Alpharma). To visualize lipid droplets fixed cells were stained with Oil Red-O as described earlier [3].
###end p 52
###begin title 53
Quantitative RT-PCR
###end title 53
###begin p 54
###xml 319 323 319 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 388 390 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 397 401 395 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 561 563 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 571 577 543 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 605 607 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 774 775 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 837 839 809 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 850 852 822 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 983 984 955 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Total RNA was purified using the DNAse-containing RNeasy Micro Kit (Qiagen). RT-PCR was carried out from 500 ng total RNA using the Iscript cDNA synthesis kit (BioRad). Quantitative RT-PCR reactions were performed in triplicates from two separate cDNA preparations on a MyiQ Real-time PCR Detection System using IQ SYBR(R) Green (BioRad). RT-PCR primers used have been published earlier [10]. SYBR(R) Green PCR conditions were 95degreesC for 4.5 min and 40 cycles of 95degreesC 30 sec, 60degreesC 30 sec and 72degreesC 30 sec, and transcript levels calculated [29] using GAPDH as a normalization control [10]. RT-blank control PCRs showed no product amplification for all genes examined in this study (data not shown). Relative transcripts levels were compared using paired t-tests and statistical significance expressed as a two-tailed P value with P < 0.05 considered as significant. When relevant, transcript levels were compared to a "reference" level (level 1) using one-sample t-tests.
###end p 54
###begin title 55
Bisulfite sequencing
###end title 55
###begin p 56
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 341 348 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2 </italic>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 490 496 490 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 602 606 602 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 785 787 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
Methylation of four adipogenic gene promoters was analyzed by bisulfite sequencing. The LEP promoter region examined, and known to be regulated by methylation [44], covered nucleotides 2719-2937 (GenBank ) and spanned 27 potentially methylated cytosines within nucleotides -203 to +16 with respect to the transcription start site (TSS). The PPARG2 promoter region [55] spanned nucleotides 108-587 (GenBank ) and included 6 CpGs within nucleotides -620 to - 140 with respect to the TSS. The FABP4 (GenBank ) promoter region encompassed 4 CpGs within nucleotides -478 to -65 with respect to the TSS. The LPL promoter region (GenBank ) spanned bases 1321-1777 and included 11 CpGs within nucleotides -398 to +59 with respect to the TSS. Sequence positioning was identified using Ensembl [56].
###end p 56
###begin p 57
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 699 702 693 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
###xml 716 722 710 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 724 730 718 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 734 738 728 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL </italic>
###xml 770 772 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 799 801 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 808 814 802 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG2</italic>
###xml 816 822 810 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FABP4 </italic>
###xml 826 829 820 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPL</italic>
###xml 984 987 948 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP</italic>
###xml 1186 1194 1120 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 353 358 <span type="species:ncbi:9606">Human</span>
###xml 669 674 <span type="species:ncbi:9606">Human</span>
###xml 1186 1193 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
For bisulfite conversion, DNA was purified by phenol-chloroform-isoamylalcohol extraction. Cells were lysed for 10 min in lysis buffer (10 mM Tris-HCl, pH 8, 100 mM EDTA, 0.5% SDS) and digested with 0.1 mg/ml Proteinase K overnight. Bisulfite conversion was performed using the MethylEasy DNA Bisulfite Modification kit as detailed by the manufacturer (Human Genetic Signatures) [10]. Conversion rates, assessed by conversion of all cytosines in non-CpG dinucleotides to uracils (reading as thymidines after PCR), was 100% (data not shown). Converted DNA was used fresh or stored at -20degreesC. Converted DNA was amplified by PCR using primers commercially available (Human Genetic Signatures) for LEP. Primers for PPARG2, FABP4 and LPL were designed using Methprimer [57] and previously reported [10]. For PPARG2, FABP4 and LPL, PCR conditions were 95degreesC for 7 min and 40 cycles of 95degreesC 1 min, 54degreesC 2 min and 72degreesC 2 min, followed by 10 min at 72degreesC. For LEP, nested PCRs were performed, each with 95degreesC for 3 min and 30 cycles of 95degreesC 1 min, 50degreesC 2 min and 72degreesC 2 min, followed by 10 min at 72degreesC. PCR products were cloned into E. coli by TOPO TA cloning (Invitrogen) and reverse-sequenced (MWG Biotech).
###end p 57
###begin p 58
###xml 346 347 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 455 456 455 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 511 513 511 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Methylation data are represented as filled circles (methylated CpG) and empty circles (unmethylated CpG) for each bacterial clone obtained. Each row of circles represents methylation pattern based on the sequence of one cloned PCR product (i.e., one genomic allele). Global methylation percentages for a given promoter were compared using paired t-tests. Numbers of methylated cytosines for a given CpG were compared between cell populations using paired t-tests and significance was expressed using two-tailed P values.
###end p 58
###begin title 59
Abbreviations
###end title 59
###begin p 60
ASC, adipose stem cells; MSC, mesenchymal stem cell; PCR, polymerase chain reaction, TSS, transcription start site
###end p 60
###begin title 61
Authors' contributions
###end title 61
###begin p 62
AN: experimental design, all practical work, data analysis, figures, writing. ACB: derivation of ASC clones, differentiation. PC: experimental design, figures, supervision, writing. All authors read and approved the final manuscript.
###end p 62
###begin title 63
Supplementary Material
###end title 63
###begin title 64
Additional file 1
###end title 64
###begin p 65
###xml 368 372 368 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEP </italic>
Supplementary Figures with legends. The data provided show DNA methylation profiles for adipogenic gene promoters in undifferentiated P4 and senescent ASCs (Supplementary Figure 1), and after three weeks of adipogenic differentiation at P4 and upon senescence (Supplementary Figure 2). Supplementary Figure 3 provides sequencing evidence for a C:T substitution in the LEP promoter.
###end p 65
###begin p 66
Click here for file
###end p 66
###begin title 67
Acknowledgements
###end title 67
###begin p 68
We are grateful to Kristin Vekterud for technical assistance. The work was supported by the Research Council of Norway (YFF, STORFORSK, FUGE and STAMCELLE programs).
###end p 68
###begin article-title 69
###xml 24 29 <span type="species:ncbi:9606">human</span>
Multilineage cells from human adipose tissue: implications for cell-based therapies
###end article-title 69
###begin article-title 70
Fat tissue: an underappreciated source of stem cells for biotechnology
###end article-title 70
###begin article-title 71
###xml 61 66 <span type="species:ncbi:9606">human</span>
Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture
###end article-title 71
###begin article-title 72
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Adipose-derived adult stromal cells heal critical-size mouse calvarial defects
###end article-title 72
###begin article-title 73
###xml 73 78 <span type="species:ncbi:9606">human</span>
###xml 143 147 <span type="species:ncbi:10116">rats</span>
Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats
###end article-title 73
###begin article-title 74
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Reconstitution of lethally irradiated mice by cells isolated from adipose tissue
###end article-title 74
###begin article-title 75
From heterogeneity to plasticity in adipose tissues: site-specific differences
###end article-title 75
###begin article-title 76
###xml 53 58 <span type="species:ncbi:9606">human</span>
Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells
###end article-title 76
###begin article-title 77
Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood or adipose tissue
###end article-title 77
###begin article-title 78
Stable CpG hypomethylation of adipogenic promoters in freshly isolated, cultured and differentiated mesenchymal stem cells from adipose tissue
###end article-title 78
###begin article-title 79
###xml 54 59 <span type="species:ncbi:9606">human</span>
Epigenetic programming of mesenchymal stem cells from human adipose tissue
###end article-title 79
###begin article-title 80
Structure, function and evolution of CpG island promoters
###end article-title 80
###begin article-title 81
CpG methylation profiles of endothelial cell-specific gene promoter regions in adipose tissue stem cells suggest limited differentiation potential toward the endothelial cell lineage
###end article-title 81
###begin article-title 82
###xml 48 53 <span type="species:ncbi:9606">human</span>
Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion
###end article-title 82
###begin article-title 83
###xml 72 77 <span type="species:ncbi:9606">human</span>
Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation
###end article-title 83
###begin article-title 84
###xml 73 78 <span type="species:ncbi:9606">human</span>
Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy
###end article-title 84
###begin article-title 85
###xml 8 14 <span type="species:ncbi:10090">murine</span>
Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture
###end article-title 85
###begin article-title 86
Historical claims and current interpretations of replicative aging
###end article-title 86
###begin article-title 87
###xml 75 80 <span type="species:ncbi:9606">human</span>
Expression of telomerase extends longevity and enhances differentiation in human adipose tissue-derived stromal cells
###end article-title 87
###begin article-title 88
Aging of mesenchymal stem cells
###end article-title 88
###begin article-title 89
Age-related impairment of mesenchymal progenitor cell function
###end article-title 89
###begin article-title 90
Senescence and immortalization: role of telomeres and telomerase
###end article-title 90
###begin article-title 91
Stem cells, ageing and the quest for immortality
###end article-title 91
###begin article-title 92
Cancer epigenetics
###end article-title 92
###begin article-title 93
DNA methylation patterns and epigenetic memory
###end article-title 93
###begin article-title 94
Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression
###end article-title 94
###begin article-title 95
###xml 12 17 <span type="species:ncbi:9606">human</span>
Analysis of human peripheral blood T cells and single-cell-derived T cell clones uncovers extensive clonal CpG island methylation heterogeneity throughout the genome
###end article-title 95
###begin article-title 96
A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo
###end article-title 96
###begin article-title 97
A new mathematical model for relative quantification in real-time RT-PCR
###end article-title 97
###begin article-title 98
Identification and resolution of artifacts in bisulfite sequencing
###end article-title 98
###begin article-title 99
Cytosine methylation and CpG, TpG (CpA) and TpA frequencies
###end article-title 99
###begin article-title 100
###xml 75 80 <span type="species:ncbi:9606">human</span>
The covariation between TpA deficiency, CpG deficiency, and G+C content of human isochores is due to a mathematical artifact
###end article-title 100
###begin article-title 101
Aging of mesenchymal stem cell in vitro
###end article-title 101
###begin article-title 102
Transcriptional control of adipocyte formation
###end article-title 102
###begin article-title 103
Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene
###end article-title 103
###begin article-title 104
Induction of LPL gene expression by sterols is mediated by a sterol regulatory element and is independent of the presence of multiple E boxes
###end article-title 104
###begin article-title 105
Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity
###end article-title 105
###begin article-title 106
C/EBPalpha is required for differentiation of white, but not brown, adipose tissue
###end article-title 106
###begin article-title 107
Adipogenesis: cellular and molecular aspects
###end article-title 107
###begin article-title 108
Mosaic methylation in clonal tissue
###end article-title 108
###begin article-title 109
The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides
###end article-title 109
###begin article-title 110
N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso
###end article-title 110
###begin article-title 111
Regulation of leptin promoter function by Sp1, C/EBP, and a novel factor
###end article-title 111
###begin article-title 112
###xml 26 31 <span type="species:ncbi:9606">human</span>
Leptin gene expression in human preadipocytes is switched on by maturation-induced demethylation of distinct CpGs in its proximal promoter
###end article-title 112
###begin article-title 113
###xml 95 98 <span type="species:ncbi:10116">rat</span>
###xml 144 149 <span type="species:ncbi:10090">mouse</span>
###xml 154 159 <span type="species:ncbi:9606">human</span>
Cloning, sequencing and structural analysis of 976 base pairs of the promoter sequence for the rat lipoprotein lipase gene. Comparison with the mouse and human sequences
###end article-title 113
###begin article-title 114
Lipoprotein lipase: genetics, lipid uptake, and regulation
###end article-title 114
###begin article-title 115
A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease
###end article-title 115
###begin article-title 116
###xml 12 17 <span type="species:ncbi:9606">human</span>
Age-related human small intestine methylation: evidence for stem cell niches
###end article-title 116
###begin article-title 117
###xml 28 33 <span type="species:ncbi:9606">human</span>
Investigating stem cells in human colon by using methylation patterns
###end article-title 117
###begin article-title 118
Aberrant DNA methylation as a cancer-inducing mechanism
###end article-title 118
###begin article-title 119
Aberrant methylations in cancer cells: where do they come from?
###end article-title 119
###begin article-title 120
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Increased cell-to-cell variation in gene expression in ageing mouse heart
###end article-title 120
###begin article-title 121
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
Aging and genome maintenance: lessons from the mouse?
###end article-title 121
###begin article-title 122
###xml 50 55 <span type="species:ncbi:9606">human</span>
Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells
###end article-title 122
###begin article-title 123
###xml 59 64 <span type="species:ncbi:9606">human</span>
The organization, promoter analysis, and expression of the human PPARgamma gene
###end article-title 123
###begin article-title 124
###xml 11 16 <span type="species:ncbi:9606">Human</span>
e! Ensembl Human
###end article-title 124
###begin article-title 125
MethPrimer - Design Primers for Methylation PCRs
###end article-title 125

